I. Introduction
Blood transfusion is a life-saving intervention. However, it always carries potential risks for the recipient like transfusion related adverse reactions, transfusion transmissible infections, alloimmunization etc. Blood is an expensive and scarce resource. Therefore, unnecessary transfusions may cause a shortage for those patients who are in real need and also exposure to unnecessary risks for the recipients.Blood transfusion should be prescribed only when benefits are likely to outweigh the risks. [1] .For many decades the decision to transfuse red blood cells was based upon the "10/30"; transfusion was used to maintain a blood haemoglobin concentration above 10g/dl and a haematocrit above 30% [2] . Later,a large body of clinical evidence was generated resulting in the publication of many guidelines for red blood transfusion in different settings. [3, 4] .A common theme of these guidelines is the need to balance the benefit of treating anaemia with the desire to avoid unnecessary transfusion with its associated costs and potential harms. Avoidance of single unit transfusion is one of the measures of rational use of blood. The objective of the study is to know the incidence and pattern of single unit blood transfusion in Regional Institute of Medical Sciences, Imphal.
II. Materials And Methods
The period of study was from January 2014 to Dec 2015 (24 months).Scrutiny of blood transfusion request forms received in the Department of Immonohaematology and Blood Transfusion, Regional Institute of Medical Sciences, Imphal was done and the details of the patients regarding clinical diagnosis, age, sex, haemoglobin(Hb) value, indication of transfusion and blood/ component ordered were recorded.Blood unit issued was also noted.Only Packed RBC/Whole blood(WB) units issued and utilised were taken into account.Single blood unit transfusions were selected and recorded for analysis.Congenital anaemia cases e.g. Thalassaemia, Sickle cell anaemia etc. were excluded because of single unit transfusion at regular intervals.
III. Results
A total of22546 PRBC/WB units were issued from Jan 2014 to Dec 2015, out of which single unit transfusion constituted 2232units (9.9%). 
IV. Discussion
According to WHO guidelines,blood transfusion should be prescribed only for conditions with significant potential for morbidity or mortality that cannot be prevented or managed effectively by other means. Careful assessment of clinical and laboratory indications are necessary. Haemoglobin value although important, should not be the sole deciding factor for blood transfusion, particularly in blood loss. [1] . There is general agreement that RBC transfusion is indicated if Hb level is< 7 to 8gm/dl and not indicated when Hb levels of > 10gm/dl in stable ,nonbleeding medical and surgical inpatients. [5, 6] .RBC transfusion is indicated in patients who are actively bleeding and should be based on clinical assessment in addition to laboratory testing. A recent study examining transfusion in patients with active gastrointestinal bleeding showed superior outcomes in patients with a restrictive transfusion (Hb< 7gm/dl). [7] . In our hospital we also recommend RBC transfusion when Hb is <7gm/dl ; to consider transfusion when Hb is between 7-10 gm/dl if associated with symptoms or cardio-respiratory insufficiency and no transfusion when Hb is> 10gm/dl in non-bleeding patient. One unit of PRBC/whole blood would raise approximately 1gm/dl of Hb which is therapeutically insignificant. [8] .
In our study, we have felt that patients with Hb>7 to 10 gm/dl, single unit transfusion could have been avoided in good number of cases with the use of other safer alternatives. Patients with Hb> 10 gm/dl, blood transfusion was not justified.Based on these criteria and the available clinical details ,480 single unit transfusions out of 2232 units were unjustified (21.5 %).Majority of the patients were labelled as full term pregnancy with anticipated bleeding, chronic anaemia, anaemia under evaluation, alcoholic liver disease with anaemia, diabetes mellitus with hypertension, preoperative with anticipated bleeding etc. which are not valid reasons for transfusion.
Some guidelines recommend single unit transfusion with the reasons that it reduces the patient's exposure to allogenic blood with more than one unit transfusion and possibility of dose-dependent increased risk of nosocomial infection and other morbidities.They also recommend to transfuse one unit at a time and only when clinically indicated, based on the need to relieve clinical signs and symtoms of anaemia. If one unit has achieved the stated outcome for the red cell transfusion, further units will only increase the risks. (9, 10, 11 ) .In our context of more demand, less supply and limited resources , we advocate restriction of single unit transfusion unless indicated.
In a study by Vachhani JH et al , single unit transfusion constituted 55.1% of all transfusions. After having group discussions and awareness sessions with clinicians , the single unit transfusions came down to 52.81%. [12] .In other studies the percentage of single unit transfusion were 38.9% [13] and 21.6%, [14] respectively. In our study the percentage of 9.9 % is comparatively lower. WHO advocates that the need of transfusion can be avoided by prevention or early diagnosis and treatment of anaemia,correction of anaemia and replacement of depleted iron stores before planned surgery and use of simple alternatives to transfusion like intravenous replacement fluids, good anaesthetic and surgical management.Blood should not be given for volume expansion ,as haematinic / tonic, to enhance wound healing or to improve general well-being. If given when it is not needed, the patient receives no benefit and is exposed to unnecessary risk. (1 ) .
